135 related articles for article (PubMed ID: 25712853)
1. Engineering poly(ethylene glycol) particles for improved biodistribution.
Cui J; De Rose R; Alt K; Alcantara S; Paterson BM; Liang K; Hu M; Richardson JJ; Yan Y; Jeffery CM; Price RI; Peter K; Hagemeyer CE; Donnelly PS; Kent SJ; Caruso F
ACS Nano; 2015 Feb; 9(2):1571-80. PubMed ID: 25712853
[TBL] [Abstract][Full Text] [Related]
2. Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and
Song J; Ju Y; Amarasena TH; Lin Z; Mettu S; Zhou J; Rahim MA; Ang CS; Cortez-Jugo C; Kent SJ; Caruso F
ACS Nano; 2021 Jun; 15(6):10025-10038. PubMed ID: 34009935
[TBL] [Abstract][Full Text] [Related]
3. Room-temperature preparation and characterization of poly (ethylene glycol)-coated silica nanoparticles for biomedical applications.
Xu H; Yan F; Monson EE; Kopelman R
J Biomed Mater Res A; 2003 Sep; 66(4):870-9. PubMed ID: 12926040
[TBL] [Abstract][Full Text] [Related]
4. Templated Polymer Replica Nanoparticles to Facilitate Assessment of Material-Dependent Pharmacokinetics and Biodistribution.
Song D; Cui J; Sun H; Nguyen TH; Alcantara S; De Rose R; Kent SJ; Porter CJH; Caruso F
ACS Appl Mater Interfaces; 2017 Oct; 9(39):33683-33694. PubMed ID: 28945344
[TBL] [Abstract][Full Text] [Related]
5. Nanoengineering of Poly(ethylene glycol) Particles for Stealth and Targeting.
Cui J; Björnmalm M; Ju Y; Caruso F
Langmuir; 2018 Sep; 34(37):10817-10827. PubMed ID: 30132674
[TBL] [Abstract][Full Text] [Related]
6. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
[TBL] [Abstract][Full Text] [Related]
7. Modulating Targeting of Poly(ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies.
Cui J; Ju Y; Houston ZH; Glass JJ; Fletcher NL; Alcantara S; Dai Q; Howard CB; Mahler SM; Wheatley AK; De Rose R; Brannon PT; Paterson BM; Donnelly PS; Thurecht KJ; Caruso F; Kent SJ
Adv Healthc Mater; 2019 May; 8(9):e1801607. PubMed ID: 30868751
[TBL] [Abstract][Full Text] [Related]
8. Surface-initiated polymerization within mesoporous silica spheres for the modular design of charge-neutral polymer particles.
Müllner M; Cui J; Noi KF; Gunawan ST; Caruso F
Langmuir; 2014 Jun; 30(21):6286-93. PubMed ID: 24834480
[TBL] [Abstract][Full Text] [Related]
9. Ligand-Functionalized Poly(ethylene glycol) Particles for Tumor Targeting and Intracellular Uptake.
Cui J; Alt K; Ju Y; Gunawan ST; Braunger JA; Wang TY; Dai Y; Dai Q; Richardson JJ; Guo J; Björnmalm M; Hagemeyer CE; Caruso F
Biomacromolecules; 2019 Sep; 20(9):3592-3600. PubMed ID: 31448896
[TBL] [Abstract][Full Text] [Related]
10. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity.
Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R
Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018
[TBL] [Abstract][Full Text] [Related]
11. Size dependent biodistribution and SPECT imaging of (111)In-labeled polymersomes.
Brinkhuis RP; Stojanov K; Laverman P; Eilander J; Zuhorn IS; Rutjes FP; van Hest JC
Bioconjug Chem; 2012 May; 23(5):958-65. PubMed ID: 22463082
[TBL] [Abstract][Full Text] [Related]
12. Engineering poly(ethylene glycol) particles for targeted drug delivery.
Li S; Ma Y; Cui J; Caruso F; Ju Y
Chem Commun (Camb); 2024 Feb; 60(19):2591-2604. PubMed ID: 38285062
[TBL] [Abstract][Full Text] [Related]
13. Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent.
Adzamli K; Dorshow RB; Hynes MR; Nosco DL; Adams MD
Acta Radiol Suppl; 1997; 412():73-8. PubMed ID: 9240084
[TBL] [Abstract][Full Text] [Related]
14. Grafting of poly(ethylene glycol) to poly-lysine augments its lifetime in blood circulation and accumulation in tumors without loss of the ability to associate with siRNA.
Kano A; Moriyama K; Yamano T; Nakamura I; Shimada N; Maruyama A
J Control Release; 2011 Jan; 149(1):2-7. PubMed ID: 20005270
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and antimycobacterial property of PEG-bis(INH) conjugates.
Kakkar D; Tiwari AK; Chuttani K; Khanna A; Datta A; Singh H; Mishra AK
Chem Biol Drug Des; 2012 Aug; 80(2):245-53. PubMed ID: 22515497
[TBL] [Abstract][Full Text] [Related]
16. Size and rigidity of cylindrical polymer brushes dictate long circulating properties in vivo.
Müllner M; Dodds SJ; Nguyen TH; Senyschyn D; Porter CJ; Boyd BJ; Caruso F
ACS Nano; 2015 Feb; 9(2):1294-304. PubMed ID: 25634484
[TBL] [Abstract][Full Text] [Related]
17. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
18. Compositional control of poly(ethylene glycol) hydrogel modulus independent of mesh size.
Browning MB; Wilems T; Hahn M; Cosgriff-Hernandez E
J Biomed Mater Res A; 2011 Aug; 98(2):268-73. PubMed ID: 21626658
[TBL] [Abstract][Full Text] [Related]
19. Core-shell structured luminescent and mesoporous β-NaYF4:Ce3+/Tb3+@mSiO2-PEG nanospheres for anti-cancer drug delivery.
Wu Y; Yang D; Kang X; Ma P; Huang S; Zhang Y; Li C; Lin J
Dalton Trans; 2013 Jul; 42(27):9852-61. PubMed ID: 23689234
[TBL] [Abstract][Full Text] [Related]
20. Tuning particle biodegradation through polymer-peptide blend composition.
Gunawan ST; Kempe K; Such GK; Cui J; Liang K; Richardson JJ; Johnston AP; Caruso F
Biomacromolecules; 2014 Dec; 15(12):4429-38. PubMed ID: 25360899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
